196 related articles for article (PubMed ID: 10814674)
1. Cancer risk and the ATM gene: a continuing debate.
Khanna KK
J Natl Cancer Inst; 2000 May; 92(10):795-802. PubMed ID: 10814674
[TBL] [Abstract][Full Text] [Related]
2. Ataxia telangiectasia gene mutations in leukaemia and lymphoma.
Boultwood J
J Clin Pathol; 2001 Jul; 54(7):512-6. PubMed ID: 11429421
[TBL] [Abstract][Full Text] [Related]
3. Ataxia-telangiectasia, cancer and the pathobiology of the ATM gene.
Meyn MS
Clin Genet; 1999 May; 55(5):289-304. PubMed ID: 10422797
[TBL] [Abstract][Full Text] [Related]
4. Ataxia-telangiectasia genes and breast cancer risk in a French family study.
Andrieu N; Cavaciuti E; Laugé A; Ossian K; Janin N; Hall J; Stoppa-Lyonnet D
J Dairy Res; 2005; 72 Spec No():73-80. PubMed ID: 16180724
[TBL] [Abstract][Full Text] [Related]
5. ATM mutations in sporadic lymphoid tumours.
Stankovic T; Stewart GS; Byrd P; Fegan C; Moss PA; Taylor AM
Leuk Lymphoma; 2002 Aug; 43(8):1563-71. PubMed ID: 12400598
[TBL] [Abstract][Full Text] [Related]
6. ATM signaling and genomic stability in response to DNA damage.
Lavin MF; Birrell G; Chen P; Kozlov S; Scott S; Gueven N
Mutat Res; 2005 Jan; 569(1-2):123-32. PubMed ID: 15603757
[TBL] [Abstract][Full Text] [Related]
7. Mice heterozygous for mutation in Atm, the gene involved in ataxia-telangiectasia, have heightened susceptibility to cancer.
Spring K; Ahangari F; Scott SP; Waring P; Purdie DM; Chen PC; Hourigan K; Ramsay J; McKinnon PJ; Swift M; Lavin MF
Nat Genet; 2002 Sep; 32(1):185-90. PubMed ID: 12195425
[TBL] [Abstract][Full Text] [Related]
8. Impaired genomic stability and increased oxidative stress exacerbate different features of Ataxia-telangiectasia.
Ziv S; Brenner O; Amariglio N; Smorodinsky NI; Galron R; Carrion DV; Zhang W; Sharma GG; Pandita RK; Agarwal M; Elkon R; Katzin N; Bar-Am I; Pandita TK; Kucherlapati R; Rechavi G; Shiloh Y; Barzilai A
Hum Mol Genet; 2005 Oct; 14(19):2929-43. PubMed ID: 16150740
[TBL] [Abstract][Full Text] [Related]
9. Clustering of missense mutations in the ataxia-telangiectasia gene in a sporadic T-cell leukaemia.
Vorechovský I; Luo L; Dyer MJ; Catovsky D; Amlot PL; Yaxley JC; Foroni L; Hammarström L; Webster AD; Yuille MA
Nat Genet; 1997 Sep; 17(1):96-9. PubMed ID: 9288106
[TBL] [Abstract][Full Text] [Related]
10. The ataxia telangiectasia gene in familial and sporadic cancer.
Yuille MA; Coignet LJ
Recent Results Cancer Res; 1998; 154():156-73. PubMed ID: 10026998
[TBL] [Abstract][Full Text] [Related]
11. Ataxia-telangiectasia: mild neurological presentation despite null ATM mutation and severe cellular phenotype.
Alterman N; Fattal-Valevski A; Moyal L; Crawford TO; Lederman HM; Ziv Y; Shiloh Y
Am J Med Genet A; 2007 Aug; 143A(16):1827-34. PubMed ID: 17632790
[TBL] [Abstract][Full Text] [Related]
12. Genotype-phenotype relationships in ataxia-telangiectasia and variants.
Gilad S; Chessa L; Khosravi R; Russell P; Galanty Y; Piane M; Gatti RA; Jorgensen TJ; Shiloh Y; Bar-Shira A
Am J Hum Genet; 1998 Mar; 62(3):551-61. PubMed ID: 9497252
[TBL] [Abstract][Full Text] [Related]
13. Cancer risks and mortality in heterozygous ATM mutation carriers.
Thompson D; Duedal S; Kirner J; McGuffog L; Last J; Reiman A; Byrd P; Taylor M; Easton DF
J Natl Cancer Inst; 2005 Jun; 97(11):813-22. PubMed ID: 15928302
[TBL] [Abstract][Full Text] [Related]
14. p53 centrosomal localization diagnoses ataxia-telangiectasia homozygotes and heterozygotes.
Prodosmo A; De Amicis A; Nisticò C; Gabriele M; Di Rocco G; Monteonofrio L; Piane M; Cundari E; Chessa L; Soddu S
J Clin Invest; 2013 Mar; 123(3):1335-42. PubMed ID: 23454770
[TBL] [Abstract][Full Text] [Related]
15. Missense mutations but not allelic variants alter the function of ATM by dominant interference in patients with breast cancer.
Scott SP; Bendix R; Chen P; Clark R; Dork T; Lavin MF
Proc Natl Acad Sci U S A; 2002 Jan; 99(2):925-30. PubMed ID: 11805335
[TBL] [Abstract][Full Text] [Related]
16. The role of ATM in breast cancer development.
Prokopcova J; Kleibl Z; Banwell CM; Pohlreich P
Breast Cancer Res Treat; 2007 Aug; 104(2):121-8. PubMed ID: 17061036
[TBL] [Abstract][Full Text] [Related]
17. The ATM gene and ataxia telangiectasia.
Mavrou A; Tsangaris GT; Roma E; Kolialexi A
Anticancer Res; 2008; 28(1B):401-5. PubMed ID: 18383876
[TBL] [Abstract][Full Text] [Related]
18. ATM mutations and phenotypes in ataxia-telangiectasia families in the British Isles: expression of mutant ATM and the risk of leukemia, lymphoma, and breast cancer.
Stankovic T; Kidd AM; Sutcliffe A; McGuire GM; Robinson P; Weber P; Bedenham T; Bradwell AR; Easton DF; Lennox GG; Haites N; Byrd PJ; Taylor AM
Am J Hum Genet; 1998 Feb; 62(2):334-45. PubMed ID: 9463314
[TBL] [Abstract][Full Text] [Related]
19. Dominant negative ATM mutations in breast cancer families.
Chenevix-Trench G; Spurdle AB; Gatei M; Kelly H; Marsh A; Chen X; Donn K; Cummings M; Nyholt D; Jenkins MA; Scott C; Pupo GM; Dörk T; Bendix R; Kirk J; Tucker K; McCredie MR; Hopper JL; Sambrook J; Mann GJ; Khanna KK
J Natl Cancer Inst; 2002 Feb; 94(3):205-15. PubMed ID: 11830610
[TBL] [Abstract][Full Text] [Related]
20. ATM and genome maintenance: defining its role in breast cancer susceptibility.
Khanna KK; Chenevix-Trench G
J Mammary Gland Biol Neoplasia; 2004 Jul; 9(3):247-62. PubMed ID: 15557798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
